Active and Mild Chronic Necrotizing Crescentic Glomerulonephritis With Severe Medullary Angiitis in an Elderly Male Patient: A Case Report

老年男性患者活动性轻度慢性坏死性新月体肾小球肾炎伴严重髓质血管炎:病例报告

阅读:1

Abstract

Pauci-immune crescentic glomerulonephritis (GN) is a rapidly progressive form of GN typically associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and may present with rare but severe histologic findings such as medullary angiitis. We describe a 69-year-old male patient with no prior medical history who presented with worsening renal function following a recent hospitalization for what is thought to be pneumonia and presumed prerenal azotemia. On readmission, he was found to have an elevated serum creatinine of 5.42 mg/dL, significant hematuria and proteinuria, elevated inflammatory markers, and normocytic anemia. Further evaluation revealed positive P-ANCA at a 1:640 titer and elevated serum IgG. A renal biopsy confirmed the diagnosis of pauci-immune necrotizing crescentic GN with both acute and chronic features, severe medullary angiitis, and arterial nephrosclerosis. The patient was treated with intravenous pulse methylprednisolone, followed by rituximab and avacopan, resulting in significant improvement in renal function without the need for dialysis. This case highlights the diagnostic challenge of distinguishing intrinsic renal disease from prerenal azotemia in the setting of acute illness and underscores the importance of considering AAV in patients presenting with unexplained acute kidney injury and systemic inflammatory markers. Medullary angiitis, although infrequently reported, may be associated with more severe renal disease and should be recognized as a potential marker of disease severity. Early biopsy and prompt initiation of immunosuppressive therapy can lead to substantial renal recovery, even in the presence of chronic histologic damage.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。